Tenzing Acquisition Corp. (TZAC) Adds a Backstop

Tenzing Acquisition Corp. (NASDAQ:TZAC) announced in an 8-K filing this morning that it has entered into a backstop agreement ahead of its shareholder vote to approve its combination with Reviva Pharmaceutics. According to the agreement, Reviva and other investors to purchase a total 417,518 shares through either private or open-market transactions by October 23. For
Read More